CBUS
Cibus Global LLC
NASDAQ: CBUS · HEALTHCARE · BIOTECHNOLOGY
$1.40
+9.37% today
Updated 2026-04-30
Market cap
$114.42M
P/E ratio
—
P/S ratio
31.44x
EPS (TTM)
$-2.78
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
WallStSmart proprietary scores
14
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+4.5
Quality
C2.5
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-3.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$14.67
+947.86%
12-Month target
—
—
Intrinsic (DCF)
$16.78
Margin of safety
+87.54%
0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 87.54% below intrinsic value
Risks
- Altman Z -3.33 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-13.51M
- Revenue declining -12.80% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $157000.00 | $1.82M | $4.26M | $3.64M | $3.64M |
| Net income | $-16.89M | $-267.63M | $-251.39M | $-127.08M | $-31.29M |
| EPS | — | — | — | — | $-2.78 |
| Free cash flow | $-20.88M | $-50.53M | $-58.85M | $-51.17M | $-13.51M |
| Profit margin | -10,758.60% | -14,729.06% | -5,898.36% | -3,492.31% | — |
Peer comparison
Smart narrative
Cibus Global LLC trades at $1.40. Our Smart Value Score of 14/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -3.33, it sits in the distress. TTM revenue stands at $3.64M. Our DCF model estimates intrinsic value at $16.78.
Frequently asked questions
What is Cibus Global LLC's stock price?
Cibus Global LLC (CBUS) trades at $1.40.
Is Cibus Global LLC overvalued?
Smart Value Score 14/100 (Grade F, Strong Sell). DCF value $16.78.
What is the price target of Cibus Global LLC (CBUS)?
The analyst target price is $14.67, representing +947.9% upside from the current price of $1.40.
What is the intrinsic value of Cibus Global LLC (CBUS)?
Based on our DCF model, intrinsic value is $16.78, a +87.5% margin of safety versus $1.40.
What is Cibus Global LLC's revenue?
TTM revenue is $3.64M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-3.33 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio31.44x
ROE-221.00%
Beta1.93
50D MA$2.57
200D MA$1.81
Shares out0.08B
Float0.05B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—